Variable | Acidotic group (n= 290) | Controls (n= 88) | P value |
---|---|---|---|
Demographics | |||
Male | 143 (49) | 36 (41) | 0.167a |
Age (years) | 80 ± 10 (n = 290) | 81 ± 9.5 (n = 88) | 0.360b |
Comorbidities | |||
Chronic obstructive pulmonary disease | 84 (29) | 17/86 (20) | 0.091a |
Essential hypertension | 162 (56) | 46/86 (54) | 0.697a |
Diabetes mellitus | 72 (25) | 19/86 (22) | 0.603a |
Congestive heart failure | 165 (57) | 51/86 (59) | 0.692a |
Chronic renal failure | 76 (26) | 13/86 (15) | 0.034a |
Severity of the disease | |||
Simplified Physiologic Acute Score II | 42 ± 6.7 (n = 258) | 40 ± 8.1 (n = 74) | 0.014b |
Physical findings | |||
Systolic blood pressure (mmHg) | 173 ± 30 (n = 286) | 170 ± 31 (n = 87) | 0.328b |
Diastolic blood pressure (mmHg) | 99 ± 20 (n = 283) | 97 ± 19 (n = 87) | 0.391b |
Systolic <140 mmHg and diastolic <90 mmHg | 32 (11) | 9 (10) | 0.802b |
Heart rate (beats/minute) | 116 ± 22 (n = 283) | 121 ± 22 (n = 87) | 0.163b |
Heart rate >100 beats/minute | 197/283 (70) | 53/87 (61) | 0.130a |
Respiratory rate (breaths/minute) | 41 ± 6.1 (n = 175) | 39 ± 6.9 (n = 64) | 0.016b |
Respiratory rate ≥40 breaths/minute | 120/175 (69) | 30/64 (47) | 0.002a |
Arterial blood gas analysis | |||
pH | 7.22 ± 0.09 (n = 290) | 7.39 ± 0.03 (n = 88) | Not applicable |
PaCO2 (mmHg) | 53 ±16 (n = 290) | 36 ±6.6 (n = 88) | <0.001b |
Bicarbonates (mmol/l) | 22 ± 5.3 (n = 288) | 22 ± 3.8 (n = 88) | 0.330b |
PaO2/FiO2 ratio | 178 ± 93 (n = 283) | 222 ± 82 (n = 87) | <0.001b |
PaO2/FiO2 ratio <200 | 184/283 (65) | 32/87 (37) | <0.001a |
Acute myocardial infarction on admission | 43 (15) | 14 (16) | 0.804a |
CPAP setting | |||
Initial FiO2 (%) | 49.7 ± 12.1 (n = 288) | 48.6 ± 11.4 (n = 88) | 0.421b |
Initial PEEP (cmH2O) | 9.7 ± 2.0 (n = 290) | 9.7 ± 1.3 (n = 88) | 0.927b |
Device | |||
Face mask | 38 (19) | 15 (24) | 0.475a |
Helmet | 157 (81) | 48 (76) | |
Information not available | 95 | 29 |